Modeling a particular decision process by using a modulatory activation function.

Jairo Diniz Filho; Teresa B Ludermir

doi:10.1142/s0129065703001509

Home/Archive/PubMed

PubMed · 12923924

Modeling a particular decision process by using a modulatory activation function.

Jairo Diniz Filho·Teresa B Ludermir

View original source ↗Export metadata ↓

Abstract

Neuronal groups projecting widely in the brain are being experimentally associated to attention and mood changes. Those groups are known to exert a modulatory effect over other larger groups. On the other hand, some people think of the brain functions as being performed by specialized modular systems. In this work, we propose an architecture of modular nature to explore a particular decision process. We show the importance of the modulatory effect of a special evaluation segment in that process.

Explore related subjects

Affect Animals Attention Behavior Brain Computer Simulation Decision Making Environment Humans Internal-External Control Models, Neurological Neural Networks, Computer Neurons Random Allocation Set, Psychology Subject Headings Comparative Study Journal Article

Keep this discovery

Explore connections, maps & timelines

BibTeX RIS

Jairo Diniz Filho, Teresa B Ludermir. 2003. Modeling a particular decision process by using a modulatory activation function.. https://doi.org/10.1142/s0129065703001509

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related citations

PubMed2003

Drug research: the ups and downs of lithium.

Explore the source record for details and available documents.

Affect↗

PubMed2003

Affective style and in vivo immune response: neurobehavioral mechanisms.

Considerable evidence exists to support an association between psychological states and immune function. However, the mechanisms by which such states are instantiated in the brain and influence the immune system are poorly understood. The present study investigated relations among physiological measures of affective style, psychological well being, and immune function. Negative and positive affect were elicited by using an autobiographical writing task. Electroencephalography and affect-modulated eye-blink startle were used to measure trait and state negative affect. Participants were vaccinated for influenza, and antibody titers after the vaccine were assayed to provide an in vivo measure of immune function. Higher levels of right-prefrontal electroencephalographic activation and greater magnitude of the startle reflex reliably predicted poorer immune response. These data support the hypothesis that individuals characterized by a more negative affective style mount a weaker immune response and therefore may be at greater risk for illness than those with a more positive affective style.

Affect↗

PubMed2003

Cognitive predictors of medication adherence among middle-aged and older outpatients with schizophrenia.

OBJECTIVE: Medication nonadherence presents a considerable problem in patients with schizophrenia. There are limited and conflicting data on the association of cognitive impairment with antipsychotic nonadherence. In this study, we evaluated the correlation of patients' scores on Mattis' Dementia Rating Scale (DRS; total and subscale scores) with scores on the Medication Management Ability Assessment (MMAA), a performance-based measure of medication management. METHODS: Participants included 110 outpatients with schizophrenia or schizoaffective disorder. Each was evaluated using the MMAA role-play tasks and the DRS. Patients also completed the Drug Attitude Inventory (DAI), and the PANSS (Positive And Negative Syndrome Scale). RESULTS: Age, DAI score, and DRS scores were all correlated with MMAA performance. In a stepwise regression analysis, only DRS scores were predictive of MMAA performance. Among the DRS subscales, conceptualization and memory were the best statistical predictors of MMAA performance. CONCLUSION: Cognitive functions, especially conceptualization and memory, were the strongest patient-related predictors of his or her ability to manage medications, over and above the effects of age, gender, education level, symptom severity, and attitudes toward medications. These results suggest a need for intervention studies focused on improving, or at least compensating for, specific cognitive deficits such as those in memory and conceptualization among patients with schizophrenia in order to improve their ability to manage medications.

Affect↗